SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.80
Ask:
77.20
Spread: 1.40 (1.847%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

SUPPLEMENTARY PROSPECTUS

13 Sep 2007 14:53

Accsys Technologies PLC13 September 2007 NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION INTO OR IN THE UNITED STATES,AUSTRALIA, CANADA OR JAPAN. 13th September 2007 AIM: AXS PUBLICATION OF SUPPLEMENTARY PROSPECTUS IN CONNECTION WITH THE OFFERING AND EURONEXT LISTING Accsys Technologies PLC (the ''Company'') announces the publication of asupplementary prospectus in connection with the proposed listing of its ordinaryshares on Euronext Amsterdam by NYSE Euronext (the "Euronext Listing") and apublic offering in The Netherlands and private placement to certaininstitutional investors outside The Netherlands of ordinary shares in theCompany (the ''Offering''). An inaccuracy in the Prospectus published by the Company on 3rd September 2007in connection with the Offering and the Euronext Listing (the "Prospectus") hassubsequently become apparent relating to the summary of the UK taxation onchargeable gains for individuals resident in the UK set out in paragraph 15.1 ofPart XI (Additional Information) of the Prospectus. In the opinion of theDirectors of the Company, this may be significant for the purposes of making aninformed assessment of the kind mentioned in sections 87A(2) of the FinancialServices and Markets Act 2000 in relation to the Ordinary Shares in the Company. The Company has therefore today published a supplementary prospectuscorrecting the inaccuracy and setting out a correct summary of the taxationposition (the "Supplementary Prospectus"). Save as disclosed in the Supplementary Prospectus, there has been no significantnew factor, material mistake or other inaccuracy relating to the informationincluded in the Prospectus. The Supplementary Prospectus has been approved by the UKLA and notified to TheNetherlands Authority for the Financial Markets (Stichting Autoriteit FinancieleMarkten) and will be made available through the Company's website from today atwww.accsysplc.com/investor_governance and through the website of NYSE Euronextat www.euronext.com (in the case of Dutch residents only). . Hard copies of theSupplementary Prospectus and any subsequent supplement to the Prospectus or theSupplementary Prospectus, may be obtained at no cost at either of the followingaddresses:- Accsys Technologies PLC (66 Hammersmith Road, London W14 8UD, United Kingdom). Fortis Bank (Nederland) N.V. (Rokin 55, 1012 KK Amsterdam, tel: +31 20 527 2467,email: prospectus@nl.fortis.com). The availability of the Supplementary Prospectus as from today will also beannounced through advertisements in the Daily Official List (OfficielePrijscourant) and in a Dutch national newspaper (Het Financieele Dagblad). Any investor who has concluded an agreement for the purchase or acquisition ofOffer Shares or who has made an offer aimed at the conclusion of an agreementfor the purchase or acquisition of Offer Shares, has the right to rescind(ontbinden) such agreement or to withdraw (herroepen) such offer, up to andincluding 5.30pm CET on Monday, 17 September 2007. Investors who wish toexercise such rescission or withdrawal rights should send a withdrawal notice,which must include the full name and address of the investor, to Fortis Bank(Nederland) N.V. by facsimile to +31 (0) 2052 71992. For further information, please contact: Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 8144 2510 Chairman & CEO Parkgreen Communications Justine Howarth +44 (0) 20 7851 7480Citigate First Financial B.V. Jose Tijssen +31 (0)20 575 4024 Frank Jansen Other information: This announcement is not an offer to sell or a solicitation of any offer to buythe securities of Accsys Technologies PLC (the "Company", and such securities,the "Securities") in the United States or in any other jurisdiction. The Securities have not been and will not be registered under the U.S.Securities Act of 1933, as amended (the "Securities Act") and may not be offeredor sold in the United States unless registered under the Securities Act or anexemption from such registration is available. No public offering of Securitiesof the Company is being made in the United States. This announcement does not constitute a prospectus. The offer to acquireSecurities pursuant to the proposed offering will be made, and any investorshould make his investment, solely on the basis of information contained in theProspectus (as supplemented by the Supplementary Prospectus) published by theCompany in connection with the Offering and the Euronext Amsterdam Listing.Copies of the Prospectus and the Supplementary Prospectus may be obtained at nocost through the website of Euronext Amsterdam (Dutch residents only) and thewebsite of the Company. All investment is subject to risk. The value of the Securities offered may godown as well as up. Past performance is no guarantee of future returns.Potential investors are advised to seek expert financial advice before makingany investment decision. In connection with the Offering, Fortis Bank (Nederland) N.V. (the "Stabilisation Manager") (or persons acting on behalf of the StabilisationManager) may over-allot shares or effect transactions with a view to supportingthe market price of the Securities at a level higher than that which mightotherwise prevail. However, there is no assurance that the Stabilisation Manager(or persons acting on behalf of the Stabilisation Manager) will undertakestabilisation action. Any stabilisation action may begin on or after the date onwhich adequate public disclosure of the final offer price of the Securities ismade and, if begun, may be ended at any time, but it must end no later than 30days after allotment of the Securities. Certain statements in this announcement are forward-looking statements. Theseforward-looking statements speak only as at the date of this announcement. Suchstatements are based on current expectations and beliefs and, by their nature,are subject to a number of known and unknown risks and uncertainties that couldcause actual results and performance to differ materially from any expectedfuture results or performance expressed or implied by the forward-lookingstatement. The information and opinions expressed in this announcement aresubject to change without notice and neither the Company nor Fortis Bank(Nederland) N.V. assumes any responsibility or obligation to update publicly orreview any of the forward-looking statements contained herein, regardless ofwhether those statements are affected by the results of new information, futureevents or otherwise. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.